T-wave alternans: Reviewing the clinical performance, understanding limitations, characterizing methodologies

Annals of Noninvasive Electrocardiology

Volumn 13, Issue 4, 2008, Pages 401-420

  Garcia, Euler De Vilhena ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Risk stratification; T wave alternans

Indexed keywords

ATENOLOL; ATROPINE; BISOPROLOL; CARVEDILOL; ESMOLOL; ISOPRENALINE; METOPROLOL; PILSICAINIDE; PROCAINAMIDE; PROPRANOLOL; ROTIGAPTIDE; SOTALOL;

CLINICAL TRIAL; DRUG DOSE ESCALATION; ELECTROCARDIOGRAM; HEART RATE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; QT DISPERSION; QT PROLONGATION; REVIEW; SUDDEN DEATH; T WAVE; T WAVE ALTERNANS;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 54349127641     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2008.00254.x     Document Type: Review

References (105)

1. Rubart D, Zipes P. Mechanisms of sudden cardiac death. J Clin Invest 2005 115 : 2305 2315.
2. Fabre A, Sheppard MN. Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death. Heart 2006 92 : 316 320.
3. Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute cardiovascular events: Placing the risks into perspective: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology - In collaboration with the American College of Sports Medicine. Circulation 2007 115 : 2358 2368.
4. Weiss JN, Karma A, Shiferaw Y, et al. From pulsus to pulseless: The saga of cardiac alternans. Circ Res 2006 98 : 1244 1253.
5. Hering HE. Experimentelle studien an säugetieren über das elektrocardiogram. Zeitschrift für experimentelle Pathologie und Therapie 1909 7 : 363 378.
6. Adam DR, Akselrod S, Cohen RJ. Estimation of ventricular vulnerability to fibrillation through T-wave time series analysis. Comput Cardiol 1981 8 : 307 310.
7. Martínez JP, Olmos S. Methodological principles of T wave alternans analysis: A unified framework. IEEE Trans Biom Eng 2005 52 : 599 613.
8. Bloomfield DM, Steinman RC, Namerow PB, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum. Circulation 2004 110 : 1885 1889.
9. Nearing BD, Verrier RL. Progressive increases in complexity of T-wave oscillations herald ischemia-induced ventricular fibrillation. Circ Res 2002 91 : 727 732.
10. Narayan SM, Bode F, Karasik PL, et al. Alternans of atrial action potentials during atrial flutter as a precursor to atrial fibrillation. Circulation 2002 106 : 1968 1973.
11. Pastore JM, Girouard SD, Laurita KR, et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999 99 : 1385 1394.
12. Chauhan VS, Downar E, Nanthakumar K, et al. Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: A human in vivo study. Am J Physiol Heart Circ Physiol 2006 290 : 79 86.
13. Selvaraj RJ, Picton P, Nanthakumar K, et al. Endocardial and epicardial repolarization alternans in human cardiomyopathy evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans. J Am Coll Cardiol 2007 49 : 338 346.
14. Wilson LD, Wan X, Rosenbaum DS. Cellular alternans: A mechanism linking calcium cycling proteins to cardiac arrhythmogenesis. Ann N Y Acad Sci 2006 1080 : 216 234.
15. Clusin WT. Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues. Am J Physiol Heart Circ Physiol 2008 294 : H1 H10.
16. Fish JM, Antzelevitch C. Cellular mechanism and arrhythmogenic potential of T-wave alternans in the brugada syndrome. J Cardiovasc Electrophysiol 2008 19 : 301 308.
17. Hayashi H, Shiferaw Y, Sato D, et al. Dynamic origin of spatially discordant alternans in cardiac tissue. Biophys J 2007 92 : 448 460.
18. Zareba W, Piotrowicz K, McNitt S, et al. Implantable cardioverter- defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II Population). Am J Cardiol 2005 95 : 1487 1491.
19. Centers for Medicare and Medicaid Services. NCD for implantable automatic defibrillators. Publication Number 100-3, Manual Section Number 20-4, Version 3, Implementation Date: Jan 27, 2005. Available at : http://www.cms.hhs.gov/mcd/ viewncd.asp?ncd_id=20.4&ncd_version=3&basket= ncd%3A20%2E4%3A3%3AImplantable+Automatic+Defibrillators. Accessed March 13, 2007.
20. Chan PS, Stein K, Chow T, et al. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J Am Coll Cardiol 2006 48 : 112 121.
21. Chow T, Kereiakes DJ, Bartone C, et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 2007 49 : 50 58.
22. Rashba EJ, Osman AF, MacMurdy K, et al. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 2002 13 : 770 775.
23. Chow T, Saghir S, Bartone C, et al. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators. Am J Cardiol 2007 100 : 598 604.
24. ABCD (Alternans Before Cardioverter Defibrillator). Progress in clinical trials. Clin Cardiol 2007 30 : 97 100.
25. Cantillon DJ, Stein KM, Markowitz SM, et al. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol 2007 50 : 166 173.
26. Laufs U, Nef H, Möllmann H, et al. Clinical trial updates and hotline sessions presented at the Scientific Session 2007 of the American Heart Association. Clin Res Cardiol 2008 97 : 1 11.
27. Ellenbogen KA, Levine JH, Berger RD, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006 113 : 776 782.
28. Koller MT, Schaer B, Wolbers M, et al. Death without prior appropriate implantable cardioverter-defibrillator therapy - a competing risk study. Circulation 2008 117 : 1918 1926.
29. Hohnloser SH, Ikeda T, Cohen RJ. Predictive accuracy of microvolt T-wave alternans testing in primary prevention patients with and without ICDs. Heart Rhythm 2008 5 Suppl 1 S36. Abstract AB18-1.
30. Sacher F, Probst V, Iesaka Y, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome - a multicenter study. Circulation 2006 114 : 2317 2324.
31. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: Insight into risk stratification. J Am Coll Cardiol 2001 37 : 1628 1634.
32. Kirchhof P, Eckardt L, Rolf S, et al. T Wave alternans does not assess arrhythmic risk in patients with Brugada syndrome. Ann Noninv Electrocardiol 2004 9 : 162 165.
33. Ikeda T, Takami M, Sugi K, et al. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninv Electrocardiol 2005 10 : 396 403.
34. Ohkubo K, Watanabe I, Okumura Y, et al. Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient. Pacing Clin Electrophysiol 2003 26 : 1900 1903.
35. Chinushi M, Washizuka T, Okumura H, et al. Intravenous administration of class I antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001 12 : 493 495.
36. Tada T, Kusano KF, Nagase S, et al. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2008 19 : 56 61.
37. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy results of the Marburg cardiomyopathy study. Circulation 2003 108 : 2883 2891.
38. Bloomfield DM, Bigger JT, Steinman RC, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006 47 : 456 463.
39. Salerno-Uriarte JA, De Ferrari GM, Klersy C, et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy - results of the ALPHA study. J Am Coll Cardiol 2007 50 : 1896 904.
40. Klingenheben T, Ptaszynski P, Hohnloser SH. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure. J Cardiovasc Electrophysiol 2005 16 : 614 618.
41. Guazzi M, Raimondo R, Vicenzi M, et al. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J Am Coll Cardiol 2007 50 : 299 308.
42. Baravelli M, Fantoni C, Rogiani S, et al. Combined prognostic value of peak O2 uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy. Int J Cardiol 2007 121 : 23 29.
43. Kon-No Y, Watanabe J, Koseki Y, et al. Microvolt T wave alternans in human cardiac hypertrophy: Electrical instability and abnormal myocardial arrangement. J Cardiovasc Electrophysiol 2001 12 : 759 763.
44. Kuroda N, Ohnishi Y, Yoshida A, et al. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy. Circ J 2002 66 : 457 462.
45. Varnava AM, Elliott PM, Mahon N, et al. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001 88 : 275 279.
46. Varnava AM, Elliott PM, Sharma S, et al. Hypertrophic cardiomyopathy: The interrelation of disarray, fibrosis, and small vessel disease. Heart 2000 84 : 476 482.
47. Fineschi V, Silver MD, Karch SB, et al. Myocardial disarray: An architectural disorganization linked with adrenergic stress? Int J Cardiol 2005 99 : 277 282.
48. Alexander ME, Cecchin F, Huang KP, et al. Microvolt T-wave alternans with exercise in pediatrics and congenital heart disease: Limitations and predictive value. Pacing Clin Electrophysiol 2006 29 : 733 741.
49. Weber S, Tillmanns H, Waldecker B. Prevalence of T wave alternans in healthy subjects. Pacing Clin Electrophysiol 2003 26 [Pt.I] : 49 52.
50. Grimm W, Liedtke J, Muller H-H. Prevalence of potential noninvasive arrhythmia risk predictors in healthy, middle-aged persons. Ann Noninv Electrocardiol 2003 8 : 37 46.
51. Cheung MMH, Davis AM, Cohen RJ, et al. T wave alternans threshold in normal children. J Cardiovasc Electrophysiol 2001 12 : 424 427.
52. Nieminen T, Lehtimäki T, Viik J, et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J 2007 28 : 2332 2337.
53. Koutlianos NA, Kouidi EJ, Metaxas TI, et al. Non-invasive cardiac electrophysiological indices in soccer players with mitral valve prolapse. Eur J Cardiovasc Prev Rehabil 2004 11 : 435 441.
54. Furlanello F, Galanti G, Manetti P, et al. Microvolt T-wave alternans as predictor of electrophysiological testing results in professional competitive athletes. Ann Noninv Electrocardiol 2004 9 : 201 206.
55. Inama G, Pedrinazzi C, Durin O, et al. Microvolt T-wave alternans for risk stratification in athletes with ventricular arrhythmias: Correlation with programmed ventricular stimulation. Ann Noninv Electrocardiol 2008 13 : 14 21.
56. Movahed M-R, Hashemzadeh M, Jamal M. Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus. Heart Vessels 2007 22 : 251 253.
57. Movahed M-R. Diabetes as a risk factor for cardiac conduction defects: A review. Diabetes Obes Metab 2007 9 : 276 281.
58. Molon G, Targher G, Costa A, et al. Measurement of microvolt T-wave alternans, a new arrhythmic risk stratification test, in Type 2 diabetic patients without clinical cardiovascular disease. Diabet Med 2006 23 : 207 210.
59. Molon G, Costa A, Bertolini L, et al. Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients. Pacing Clin Electrophysiol 2007 30 : 1267 1272.
60. Ikeda T, Yoshino H, Sugi K, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction results of a collaborative cohort study. J Am Coll Cardiol 2006 48 : 2268 2274.
61. Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction - the refine study. J Am Coll Cardiol 2007 50 : 2275 2284.
62. Ikeda T, Sakata T, Takami M, et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction - a prospective study. J Am Coll Cardiol 2000 35 : 722 730.
63. Oliveira MM, Fiarresga A, Pelicano N, et al. Temporal variations in microvolt T-wave alternans testing after acute myocardial infarction. Ann Noninv Electrocardiol 2007 12 : 98 103.
64. Yap YG, Duong T, Bland M, et al. Temporal trends on the risk of arrhythmic versus non-arrhythmic deaths in high-risk patients after myocardial infarction: A combined analysis from multicentre trials. Eur Heart J 2005 26 : 1385 1393.
65. Stein PK, Sanghavi D, Domitrovich PP, et al. Amubulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study. J Cardiovasc Electrophysiol 2008 Jun 12 Epub ahead of print doi: 10.1111/j.1540.
66. Cox V, Patel M, Kim J, et al. Predicting arrhythmia-free survival using spectral and modified-moving average analyses of T-wave alternans. Pacin Clin Electrophysiol 2007 30 : 352 358.
67. Smith JM, Clancy EA, Valeri CR, et al. Electrical alternans and cardiac electrical instability. Circulation 1988 77 : 110 121.
68. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994 330 : 235 241.
69. Nearing BD, Verrier RL. Personal computer system for tracking cardiac vulnerability by complex demodulation of the T wave. J Appl Physiol 1993 74 : 2606 2612.
70. Nearing BD, Verrier RL. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 2002 92 : 541 549.
71. Shusterman V, Goldberg A. Tracking repolarization dynamics in real-life data. J Electrocardiol 2004 37 : 180 186.
72. Shusterman V, Goldberg A, London B. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. Circulation 2006 113 : 2880 2887.
73. Lampert R, Soufer R, McPherson CA, et al. Implantable cardioverter-defibrillator shocks increase T-wave alternans. J Cardiovasc Electrophysiol 2007 18 : 1 6.
74. Raatikainen MJ, Jokinen V, Virtanen V, et al. Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction. Pacing Clin Electrophysiol 2005 28 (Suppl 1 S193 S197.
75. Shalaby AA, Voigt A, El-Saed A, et al. Microvolt T-wave alternans during atrial and ventricular pacing. Pacing Clin Electrophysiol 2007 30 : S178 S182.
76. Rashba EJ, Osman AF, MacMurdy K, et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002 13 : 845 850.
77. Bloomfield DM, Ritvo BS, Parides MK, et al. The immediate reproducibility of T wave alternans during bicycle exercise. Pacing Clin Electrophysiol 2002 25 : 1185 91.
78. Turitto G, Mirandi AP, Pedalino RP, et al. Short-term reproducibility of T-wave alternans measurement. J Cardiovasc Electrophysiol 2002 13 : 641 644.
79. Bloomfield DM, Magnano AR, Parides MK. Comparison of T-wave alternans testing during treadmill and bicycle exercise in patients with congestive heart failure. Am J Cardiol 2003 91 : 1493 1497.
80. Weber S, Schwab JO. Comparison of microvolt T-wave alternans measurements using atrial pacing compared to atropine administration. Pacing Clin Electrocardiol 2007 30 : 1487 1492.
81. Caffarone A, Martinelli A, Valentini P, et al. T wave alternans detection during exercise stress test and during dobutamine stress. A comparative study in patients with a recent myocardial infarction. (abstract) Ital Heart J 2001 2 : 265 270.
82. Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 2002 13 : 502 512.
83. Nearing BD, Oesterle SN, Verrier RL. Quantification of ischaemia induced vulnerability by precordial T wave alternans analysis in dog and human. Cardiovasc Res 1994 28 : 1440 1449.
84. Martínez JP, Olmos S, Laguna P. T wave alternans detection: A simulation study and analysis of the European ST-T database. Comput Cardiol 2000 27 : 155 158.
85. Verrier RL, Nearing BD, Kwaku KF. Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave alternans analysis: Evidence and methodological guidelines. Ann Noninv Electrocardiol 2005 10 : 110 120.
86. Verrier RL, Kwaku KF, Nearing BD, et al. T-wave alternans: Does size matter? J Cardiovasc Electrophysiol 2005 16 : 625 628.
87. Madias JE. Reproducibility of the T-wave alternans and dependence of T-wave alternans on the T-wave amplitude: 2 issues requiring immediate attention. J Electrocardiol 2007 40 : 364. e1-3.
88. Madias JE. Reproducibility of T-wave alternans in congestive heart failure: A theoretical argument. Pacing Clin Electrophysiol 2006 29 : 800 802.
89. Kaufman ES, Bloomfield DM, Steinman RC, et al. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006 48 : 1399 1404.
90. Chan PS, Bartone C, Booth T, et al. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am Heart J 2007 153 : 523 529.
91. Royston P, Altman DG and Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Statist Med 2006 25 : 127 141.
92. Verrier RL, Nearing BD, La Rovere MT, et al. Ambulatory electrocardiogram-based tracking of T-wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 2003 14 : 705 711.
93. Kop WJ, Krantz DS, Nearing BD, et al. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation 2004 109 : 1864 1869.
94. Armoundas AA, Albert CM, Cohen RJ, et al. Utility of implantable cardioverter defibrillators electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. J Cardiovasc Electrophysiol 2004 15 : 594 597.
95. Harada M, Shimizu A, Murata M, et al. Relation between microvolt-level T-wave alternans and cardiac sympathetic nervous system abnormality using iodine-123 metaiodobenzylguanidine imaging in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003 92 : 998 1001.
96. Lampert R, Shusterman V, Burg MM, et al. Effects of psychologic stress on repolarization and relationship to autonomic and hemodynamic factors. J Cardiovasc Electrophysiol 2005 16 : 372 377.
97. Lampert R, Jain D, Burg MM, et al. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter- defibrillators. Circulation 2000 101 : 158 164.
98. Ferrero P, Castagno D, Massa R, et al. Spinal cord stimulation affects T-wave alternans in patients with ischaemic cardiomyopathy: A pilot study. Europace 2008 10 : 506 508.
99. Mitchell LB, Pineda EA, Titus JL, et al. Sudden death in patients with implantable cardioverter defibrillators - the importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002 39 : 1323 1328.
100. Murata M, Harada M, Shimizu A, et al. Effect of long-term beta-blocker therapy on microvolt-level t-wave alternans in association with the improvement of the cardiac sympathetic nervous system and systolic function in patients with non-ischemic heart disease. Circ J 2003 67 : 821 825.
101. Zacks ES, Morin DP, Ageno S, et al. Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. Am Heart J 2007 153 : 392 397.
102. Klingenheben T, Grönefeld G, Li YG, et al. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol 2001 38 : 2013 2019.
103. Rashba EJ, Cooklin M, MacMurdy K, et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 2002 105 : 837 842.
104. Komiya N, Seto S, Nakao K, et al. The influence of β-adrenergic agonists and antagonists on t-wave alternans in patients with and without ventricular tachyarrhythmia. Pacing Clin Electrophysiol 2005 28 : 680 684.
105. Kjølbye AL, Dikshteyn M, Eloff BC, et al. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans. Am J Physiol Heart Circ Physiol 2008 294 : H41 H49.